Similarly, Fulton and colleagues demonstrated that genetic or pharmacological inhibition of gal3 resulted in reduced pulmonary hypertension in vivo in a model of hypoxia-induced PAH (62). Here, LGALS3 is linked to pulmonary arterial hypertension.